Zebra Capital Management LLC Coherus Bio Sciences, Inc. Transaction History

Zebra Capital Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$5.86 - $13.23 $2,162 - $4,881	-369 Reduced 2.85%	12,570 $91,000
Q1 2022 May 16, 2022	SELL	$10.92 - $16.41 $41,572 - $62,472	-3,807 Reduced 22.73%	12,939 $167,000
Q4 2021 Feb 14, 2022	SELL	$15.81 - $18.99 $97,579 - $117,206	-6,172 Reduced 26.93%	16,746 $267,000
Q3 2021 Nov 15, 2021	BUY	$12.68 - $17.79 $290,600 - $407,711	22,918 New	22,918 $368,000

135

77.9M

40.7K

50.1K

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $122M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

Get notified when there are updates to the investment portfolio of Zebra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Zebra Capital Management LLC with notifications on news.